CND Life Sciences, Inc.

Amendment
CIK: 0001841099·Biotechnology·DELAWARE·Filed: Aug 3, 2026
Total Offering

$6,316,514

Amount Sold

$6,316,514

Investors

14

First Sale

Jun 9, 2026

Offering Details

Type
Debt
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Richard J. Morello
Todd Levine
Peter Harris
Enrique Carrazana
Christopher Gibbons
Jack Seaver

Company

CND Life Sciences, Inc.

9165 E. DEL CAMINO DRIVE

SCOTTSDALE, AZ, 85258-4381

617-223-1585

SEC Filing

0001841099-26-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
CND Life Sciences, Inc. Form D Filing — $6,316,514 | FilingFlow